.
Search Results
Regen Biologics
545 Penobscot Dr, Redwood City, CA 94063
Established in 1990, Regen Biologics develops and manufactures orthopedic products with the aim of helping individualsMore continue an active lifestyle after sustaining torn cartilage. This is the company's manufacturing facility.
Facet Biotech Corporation
1400 Seaport Blvd, Redwood City, CA 94063
The Facet Biotech Corporation researches and develops biotechnology for the medical community. The company has aMore biology-driven approach to research and is focused on discovering and developing new drugs.
Star Publishing
650 El Camino Real, Redwood City, CA 94063
Star Publishing is a private publishing house that was established in 1978. The company specializes inMore publishing textbooks and reference books in accounting, biology, earth sciences, the environment and geology.
Beth Cold Acupuncturist
1121 Jefferson Ave, Redwood City, CA 94063
Beth Cold Acupuncturist is a Redwood City based acupuncturist and herbalist. The services provided are designed to treatMore conditions affecting the immune system through rubs, ointments and dietary supplements.  Acupuncture services are intended to treat behavioral conditions, curb cravings and affect changes in the biological chemistry of patients.
Valley Medical Oncology Consultants
2940 Whipple Ave, Redwood City, CA 94062
The Valley Medical Oncology Consultants offer top-notch physicians and nurses specializing in hematology and oncologyMore care. The group has several centers around the San Francisco Bay Area, including on one Whipple Avenue in Redwood City. Chemotherapy and biology therapy infusions are given at this location. The facilities are state-of-the-art. 
OncoMed Pharmaceutical
800 Chesapeake Dr, Redwood City, CA 94063
OncoMed is a Redwood City-based company that was established in 2004. This biotechnology company is focused on improvingMore cancer treatment by developing antibodies that target biological pathways known as cancer stem cells. In November 2010, OncoMed was awarded five grants that totaled $1.2 million, which will be used to continue five therapeutic programs. The company's website chronicles its research and posts recent relevant news.